We have located links that may give you full text access.
Declining Tuberculosis Incidence among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
Journal of Acquired Immune Deficiency Syndromes : JAIDS 2015 November 12
BACKGROUND: Antiretroviral therapy (ART) reduces the risk of TB among people living with HIV (PLWH). With ART scale-up in sub-Saharan Africa over the past decade, incidence of TB among PLWH engaged in HIV care is predicted to decline.
METHODS: We conducted a retrospective analysis of routine clinical data from 168,330 PLWH receiving care at 35 facilities in Kenya, Tanzania, and Uganda during 2003-2012, participating in the East African region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Temporal trends in facility-based annual TB incidence rates (per 100,000 person-years (PYs)) among PLWH and country-specific standardized TB incidence ratios (SIRs) using annual population-level TB incidence data from the World Health Organization (WHO) were computed between 2007 and 2012. We examined patient- and facility-level factors associated with incident TB using multivariable Cox models.
RESULTS: Overall, TB incidence rates among PLWH in care declined 5-fold between 2007 and 2012 from 5,960 to 985 per 100,000 PYs [p=0.0003] (Kenya: 7,552 to 1,115 [p=0.0007]; Tanzania: 7,153 to 635 [p=0.0025]; Uganda: 3,204 to 242 [p=0.018]). SIRs significantly decreased in the three countries, indicating a narrowing gap between incidence rates among PLWH and the general population. We observed lower hazards of incident TB among PLWH on ART and/or IPT and receiving care in facilities offering TB treatment on-site.
CONCLUSIONS: Annual TB incidence rates among PLWH significantly declined during ART scale-up but remained higher than the general population. Increasing access to ART and IPT and co-location of HIV and TB treatment may further reduce TB incidence among PLWH.This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
METHODS: We conducted a retrospective analysis of routine clinical data from 168,330 PLWH receiving care at 35 facilities in Kenya, Tanzania, and Uganda during 2003-2012, participating in the East African region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Temporal trends in facility-based annual TB incidence rates (per 100,000 person-years (PYs)) among PLWH and country-specific standardized TB incidence ratios (SIRs) using annual population-level TB incidence data from the World Health Organization (WHO) were computed between 2007 and 2012. We examined patient- and facility-level factors associated with incident TB using multivariable Cox models.
RESULTS: Overall, TB incidence rates among PLWH in care declined 5-fold between 2007 and 2012 from 5,960 to 985 per 100,000 PYs [p=0.0003] (Kenya: 7,552 to 1,115 [p=0.0007]; Tanzania: 7,153 to 635 [p=0.0025]; Uganda: 3,204 to 242 [p=0.018]). SIRs significantly decreased in the three countries, indicating a narrowing gap between incidence rates among PLWH and the general population. We observed lower hazards of incident TB among PLWH on ART and/or IPT and receiving care in facilities offering TB treatment on-site.
CONCLUSIONS: Annual TB incidence rates among PLWH significantly declined during ART scale-up but remained higher than the general population. Increasing access to ART and IPT and co-location of HIV and TB treatment may further reduce TB incidence among PLWH.This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app